These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 12658913

  • 21. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
    Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ.
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
    [Abstract] [Full Text] [Related]

  • 22. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M, Kuloglu M, Tezcan E, Ustundag B.
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [Abstract] [Full Text] [Related]

  • 23. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N, Foster RH, Olney R, Plosker GL.
    Drugs; 2001 May; 61(1):111-61. PubMed ID: 11217867
    [Abstract] [Full Text] [Related]

  • 24. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L, Hamer RM, Bashford RA, Sheitman BB, Lieberman JA.
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [Abstract] [Full Text] [Related]

  • 25. A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia.
    Ho BC, Miller D, Nopoulos P, Andreasen NC.
    J Clin Psychiatry; 1999 Oct; 60(10):658-63. PubMed ID: 10549681
    [Abstract] [Full Text] [Related]

  • 26. Quality of life and atypical antipsychotics.
    Rudnick A.
    J Clin Psychopharmacol; 1998 Oct; 18(5):424-5. PubMed ID: 9790165
    [No Abstract] [Full Text] [Related]

  • 27. High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.
    Heresco-Levy U, Ermilov M, Lichtenberg P, Bar G, Javitt DC.
    Biol Psychiatry; 2004 Jan 15; 55(2):165-71. PubMed ID: 14732596
    [Abstract] [Full Text] [Related]

  • 28. The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia.
    Smith RC, Infante M, Singh A, Khandat A.
    Int J Neuropsychopharmacol; 2001 Sep 15; 4(3):239-50. PubMed ID: 11669086
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial.
    Lindenmayer JP, Volavka J, Lieberman J, Sheitman B, Citrome L, Chakos M, Czobor P, Parker B, Iskander A.
    J Clin Psychopharmacol; 2001 Aug 15; 21(4):448-53. PubMed ID: 11476131
    [Abstract] [Full Text] [Related]

  • 34. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
    Sacchetti E, Valsecchi P, Parrinello G, QUERISOLA Group.
    Schizophr Res; 2008 Jan 15; 98(1-3):55-65. PubMed ID: 17933497
    [Abstract] [Full Text] [Related]

  • 35. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients.
    Koro CE, Fedder DO, L'Italien GJ, Weiss S, Magder LS, Kreyenbuhl J, Revicki D, Buchanan RW.
    Arch Gen Psychiatry; 2002 Nov 15; 59(11):1021-6. PubMed ID: 12418935
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates.
    Kasper S, Küfferle B.
    J Clin Psychopharmacol; 1998 Aug 15; 18(4):353-6. PubMed ID: 9690709
    [No Abstract] [Full Text] [Related]

  • 39. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J, Gómez JC, García-Bernardo E, Cuesta M, Alvarez E, Gurpegui M.
    J Clin Psychiatry; 1997 Nov 15; 58(11):479-83. PubMed ID: 9413413
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.